Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Torrance Dentist, Dr. Robert Mondavi, Now Uses Digital X-Rays for Comfort and Safety of the Patients

March 28, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

TORRANCE, Calif., March 28, 2011 /- Cosmetic dentist in Torrance , Dr. Robert Mondavi, DDS, utilizes the latest digital technologies in dental science to provide a safe and comfortable visit for area patients. The speed and accuracy of digital x-ray systems are revolutionizing dental...

Chimerix Appoints Timothy W. Trost Senior Vice President, Chief Financial Officer

March 28, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

DURHAM, N.C., March 28, 2011 /- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, announced today that Timothy W. Trost has joined the company as Senior Vice President, Chief Financial Officer. Mr. Trost brings to Chimerix more than 30 years of...

Everist Genomics Announces Worldwide Availability of OncoDefenderâ„¢-CRC

March 28, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., March 28, 2011 /- Everist Genomics today announced the worldwide commercial availability of its OncoDefender-CRC colorectal cancer assay, the first and only molecular prognostic test capable of accurately predicting the risk of recurrence of cancer in patients previously...

Advertisement

Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting

March 28, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, March 28, 2011 /- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) (the "Company") today announced that two abstracts on KRX-0401 (perifosine) will be presented at the upcoming 102nd annual meeting of the American Association for Cancer Research (AACR) to be held in Orlando,...

Interventional radiologists take lead on reducing disability from dangerous blood clots

March 28, 2011 5:33 am | by EurekAlert | News | Comments

(Society of Interventional Radiology) Deep vein thrombosis, or DVT: it's more than just a one-time complication from taking a long plane ride. The Society of Interventional Radiology wants individuals to know the risk factors for this very serious condition, which can lead to...

Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality

March 28, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, March 28, 2011 /- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) announced that data highlighting the burden of Clostridium difficile infection using National health insurance claims and survey databases will be presented on April 2, 2011 at the 21st Annual Scientific Meeting of...

Quest Diagnostics Commences Tender Offer for Acquisition of Celera

March 28, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

MADISON, N.J., March 28, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the...

Graymark Healthcare Reports Full Year 2010 Results

March 28, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

OKLAHOMA CITY, March 28, 2011 /- Graymark Healthcare, Inc. (Nasdaq: GRMH ), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), reported financial results for the fiscal year ended December 31, 2010....

Advertisement

Pharmasset to Webcast an Investor Event From the EASL Meeting

March 28, 2011 4:37 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., March 28, 2011 /- Pharmasset, Inc. (Nasdaq: VRUS ) today announced that it will webcast an investor event from the European Association for the Study of the Liver (EASL) on Saturday, April 2, 2011 starting at 8:00pm CET. During this webcast, management will review...

Prometheus Finds Profits in Pharmaceuticals

March 28, 2011 4:35 am | by San Diego Business Journal | News | Comments

Prometheus Inc., the Sorrento Valley-based drug and diagnostics development company, reported its 10th profitable year in a row, according to a news release.

Interventional radiology treatment takes blood pressure to new lows -- and results last

March 28, 2011 4:34 am | by EurekAlert | News | Comments

(Society of Interventional Radiology) Interventional radiologists have completed the first human randomized controlled trial of a procedure that uses high-frequency energy to deactivate the nerves near the kidneys (or in the renal artery) that are linked to high blood pressure. These...

Adeona's Multiple Sclerosis Trial Receives $409,426 Grant

March 28, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., March 28, 2011 /- Adeona Pharmaceuticals, Inc. (AMEX: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that the ongoing clinical trial of its Trimesta™ (oral estriol) drug candidate has received an additional...

Adeona to Host 2010 Year End Investor Conference Call

March 28, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., March 28, 2011 /- Adeona Pharmaceuticals, Inc. (Amex: AEN ), a developer of innovative medicines for serious central nervous system diseases, announced today that it will hold its 2010 year end investor conference call on Thursday, March 31, 2011, at 4:30pm EDT. James S....

Advertisement

Health Care Reforms Slow to Impact Real Estate

March 27, 2011 11:35 pm | by San Diego Business Journal | News | Comments

A year after landmark national health care reforms were signed into law, local observers say the impact on medical-related real estate has yet to be seen on a large scale.

Dental Biotech Firm Departs With a Smile

March 27, 2011 11:33 pm | by San Diego Business Journal | News | Comments

After finding a buyer for its only product, local dental biotech company Novalar Pharmaceuticals Inc. will cease operations at the end of the month.

Study finds changes in incidence of end-stage renal disease from lupus nephritis

March 27, 2011 9:32 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) New research documenting changes in the incidence and outcomes of end-stage renal disease (ESRD) in the US between 1995 and 2006, found a significant increase in incidence rates among patients 5 to 39 years of age and in African Americans. A second related study revealed...

Chinese Army Established the First Chest Pain Rescue Network in China by Using IVT mHealth System

March 26, 2011 5:33 pm | by Bio-Medicine.Org | News | Comments

GUANGZHOU, China, March 27, 2011 /PRNewswire-Asia/ -- Guangzhou General Hospital of Peoples Liberation Army (PLA) made a landmark announcement that the first Chinese regional military and civilian coordinated Chest Pain Rescue Network using IVT mobile health (mHealth) system is now in...

Mersana moves anti-cancer drug target along in trials

March 25, 2011 11:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Mersana Therapeutics Inc., a Cambridge cancer therapeutics developer, has begun a Phase 1b extension study of its treatment for second-line gastric cancer and second- and third-line non-small cell lung cancer.

AACR honors eminent researchers

March 25, 2011 11:33 am | by EurekAlert | News | Comments

(American Association for Cancer Research) The American Association for Cancer Research will recognize leading cancer researchers whose work has significantly contributed to progress in the fight against cancer at the AACR 102nd Annual Meeting 2011. Each recipient will present an...

FDA Approves New Treatment for a Type of Late-Stage Skin Cancer

March 25, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., March 25, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Yervoy (ipilimumab) to treat patients with late-stage (metastatic) melanoma, the most dangerous type of skin cancer. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO...

New Interim Data About Combination Oral Contraceptives

March 25, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

WAYNE, N.J., March 25, 2011 /- Bayer HealthCare Pharmaceuticals Inc. today announced that interim results from a large, prospective, observational cohort safety study offer insights into the increased risk of venous thromboembolism (VTE), or blood clots, which is a well-established risk...

CoreLab Partners Collaborates at Worldwide Industry Conferences

March 25, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., March 25, 2011 /- CoreLab Partners, Inc , the global entity resulting from the merger between RadPharm, Inc and Medifacts International, is set to attend and actively participate in several upcoming industry events around the world over the next two weeks. "The legacy of...

Med Ad News Magazine Announces Nominees for the 22nd Annual Manny Awards as Well as Advertising Person of the Year

March 25, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

NEWTOWN, Pa., March 25, 2011 /- Today, Med Ad News announces the nominees for the 22nd Annual Manny Awards and the Advertising Person of the Year. The awards ceremony will be held on Thursday, April 28, 2011, at the Sheraton New York Hotel and Towers in New York, N.Y. The Manny Awards is...

High Quality Above All Else in Your Practice, Part 1 of 2

March 25, 2011 9:34 am | by Diagnostic Imaging | News | Comments

We've considered how the competitive nature of the marketplace has influenced practice behavior, or should. Chiefly, what sets you apart? That is, what value do you add? And how do you make sure your practice is of high quality?

Utah Moves to License Radiologist Assistants

March 25, 2011 7:32 am | by Diagnostic Imaging | News | Comments

The national march toward regulating radiology extenders continues with Utah becoming the 29th state to regulate, license, or recognize radiologist assistants (RA) as part of the team.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading